Similar to LINC01134, high levels of SLC1A5 indicated worse clinical stage (Figure 4c) and shorter overall survival (OS) (Figure 4e, P=0.003, log-rank test) in CRC patients. This evidence concerns the gene SLC1A5 and colorectal carcinoma.